Listed on the Johannesburg Securities Exchange, Cipla Medpro South Africa Ltd is one of South Africa’s top ten, and fastest growing, pharmaceutical groups through its subsidiary, Cipla Medpro (Pty) Ltd. 

The Group’s operations comprise two divisions:  Cape Town-based Cipla Medpro, the country’s sixth largest pharmaceutical company and provider of an extensive range of chronic medicines and OTC (Over the Counter) products to the public and private sector; and one of the first international PIC/S compliant pharmaceutical manufacturing facilities in South Africa, Cipla Medpro Manufacturing (Pty) Ltd, based in Durban, KwaZulu-Natal which also offers contract manufacturing solutions to large local and multinational pharmaceutical companies.

Cipla Medpro South Africa Ltd replaces the former Enaleni Pharmaceuticals Ltd and trades under the abbreviated name ‘CIPLAMED’ and share code ‘CMP’.